HALIX
Live / Registered — Registered — Section 8 accepted (as of 14 Feb 2024)
What this means for you
Registered since 18 Dec 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86623209
- Registration number
- 5633165
- Mark type
- Stylized text
- Filed
- 08 May 2015
- Published for opposition
- 20 Oct 2015
- Registered
- 18 Dec 2018
Goods and services
- Class 005 — Pharmaceuticals: Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with albuterol; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension
Owner
- Concentrx Pharmaceuticals, Inc., Durham, NC, US
- Concentrx Pharmaceuticals, Inc., Durham, NC, US
- Concentrx Pharmaceuticals, Inc., Durham, NC, US
Prosecution history
- 14 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 14 Feb 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 14 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Dec 2023 — TEAS SECTION 8 RECEIVED
- 18 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 10 Nov 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Nov 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Nov 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Oct 2018 — USE AMENDMENT FILED
- 30 Oct 2018 — TEAS STATEMENT OF USE RECEIVED
- 06 Jun 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jun 2018 — SOU EXTENSION 5 GRANTED
- 30 May 2018 — SOU EXTENSION 5 FILED
- 30 May 2018 — SOU TEAS EXTENSION RECEIVED